Vancouver, B.C. and Boston, MA, June 11, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported financial results for the...
Read More
Vancouver, B.C. and Boston, MA, June 3, 2019 – Imagin Medical (CSE: IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”), an emerging leaderin the development and commercialization...
Read More
Blue Light Cystoscopy: Indications and Outcomes.
Pohar KS.
Curr Urol Rep. 2020 Apr 4;21(5):19. doi: 10.1007/s11934-020-0966-5.
PMID: 32248340 Review.
https://linkprotect.cudasvc.com/url?a=https%3a%2f%2fpubmed.ncbi.nlm.nih.gov%2f32248340%2f&c=E,1,ajK_ub6b759V3FWcq_DlZ0ZIofblOPldOaIwG1sz9awMphcRjdmSv_YwcmzyxYubp9J4Hy14OBpJrN3Gv2hKK-ehP7Nd9Xit7RpuW7syBt3qVB9flt0,&typo=1
Vancouver, B.C. and Boston, MA, April 17, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that Dr. Ashish M....
Read More
Vancouver, B.C. and Boston, MA, February 27, 2019 – Imagin Medical (CSE: IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reportedfinancial results for the three months...
Read More
Vancouver, B.C. and Boston, MA, February 19, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”), an emerging leader in the development...
Read More
Vancouver, B.C. and Boston, MA, January 23, 2018 – Imagin Medical (CSE: IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”), an emerging leader in the development and...
Read More
Vancouver, B.C. and Boston, MA, January 9, 2018 – Imagin Medical (CSE: IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced that, ahead of its planned...
Read More
